Alyssa C. Kalisky
Kirkland & Ellis LLP
- Address of record
- 333 West Wolf Point Plaza, Chicago, IL 60654, 312-862-2506
- Phone
- (312) 862-2506
- Fax
- Fax 312-862-2200
Contact details as filed with the court in the cases below.
Case history
Publicly tracked matters where this attorney is listed as counsel.
B.W. v. Invitae Corporation
This is a proposed class action against Invitae Corporation, a genetic testing and healthcare company. The case was removed from Illinois state court, but the specific allegations cannot be determined from the docket entry provided. Based on Invitae's business model, the claims likely involve issues related to genetic testing services, medical diagnostics, or related consumer health services, though the precise nature of the allegations remains unclear from the removal notice alone.
- Filed
- July 15, 2026
- Represents
- INVITAE CORPORATION
Skaggs v. X.AI Class Action
A proposed class action has been filed against X.AI, LLC in federal court in Northern California. The docket entries reference a class action complaint and a motion to dismiss, but the specific factual allegations are not disclosed in the available docket metadata. The case involves personal injury claims (Nature of Suit code 360) and remains in early stages with briefing on the motion to dismiss ongoing.
- Filed
- May 14, 2026
- Represents
- X.AI, LLC
PowerSchool/Naviance Student Data Interception Settlement
PowerSchool, Hobsons, Heap, and Chicago Public Schools allegedly non-consensually intercepted students' confidential and sensitive communications while they used the Naviance education technology platform. The defendants allegedly violated privacy laws including the Electronic Communications Privacy Act, California Invasion of Privacy Act, Illinois Eavesdropping Act, and Stored Communications Act. Defendants deny wrongdoing but agreed to settle to avoid litigation costs and uncertainties.
- Settlement fund
- $17.3M
- Claim deadline
- July 27, 2026
- Represents
- PowerSchool Holdings LLC, Hobsons, Inc.
Blue Cross Blue Shield Antitrust Settlement
Blue Cross Blue Shield companies allegedly violated antitrust laws by entering into an agreement not to compete with each other and to limit competition among themselves in selling health insurance and administrative services. The defendants deny wrongdoing and claim their conduct results in lower healthcare costs and greater access to care. The parties settled to avoid the risk and cost of further litigation.
- Settlement fund
- $2.7B
- Claim deadline
- November 5, 2021
- Represents
- Defendants' Counsel, Triple-S Salud, Inc.
“Recovery” and “exposure” refer to total disclosed settlement funds in associated cases, not money personally won or lost by an attorney. Settlements generally resolve disputed allegations without a finding that either side won. Data comes from public court dockets and may be incomplete.